Delisting Determination,The Nasdaq Stock Market, LLC,
September 23, 2019, Xynomic Pharmaceuticals Holdings, Inc. The Nasdaq
Stock Market, Inc. (the Exchange) has determined to remove
from listing the common stock of Xynomic Pharmaceuticals Holdings, Inc.
(the Company), effective at the opening of the trading
session on October 3, 2019. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rule 5101-2.
The Company was notified of the Staffs determination on
May 15, 2019.  The Company appealed the determination
to a Hearing Panel. Upon review of the information provided
by the Company, the Panel issued a decision dated
July 15, 2019, denying the Company continued listing
and notified the Company that trading in the Companys
securities would be suspended on July 17, 2019.
The Company did not request a review of the Panels decision
by the Nasdaq Listing and Hearing Review Council. The
Listing Council did not call the matter for review.
The Panels Determination to delist the Company
became final on August 29, 2019.